Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
NERV

NERV - Minerva Neurosciences Inc Stock Price, Fair Value and News

$4.17-0.18 (-4.14%)
Market Closed

Price Targets

NERV Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NERV Price Action

Last 7 days

-0.5%

Last 30 days

2.0%

Last 90 days

3.2%

Trailing 12 Months

55.6%

NERV RSI Chart

NERV Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

NERV Valuation

Market Cap

29.2M

Price/Earnings (Trailing)

-2.08

EV/EBITDA

-0.45

Price/Free Cashflow

-2.06

MarketCap/EBT

-0.83

NERV Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

NERV Fundamentals

NERV Earnings

Earnings (TTM)

-14.0M

Earnings Growth (Yr)

-112.19%

Earnings Growth (Qtr)

15.79%

NERV Profitability

Return on Equity

40.57%

Return on Assets

-49.93%

Free Cashflow Yield

-48.58%

NERV Investor Care

Diluted EPS (TTM)

-1.85

About Minerva Neurosciences Inc

NERV
Minerva Neurosciences, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of product candidates for the treatment of central nervous system diseases. Its lead product candidate is roluperidone (MIN-101) for the treatment of negative symptoms in patients with schizophrenia, currently submitted an New Drug Application (NDA); and MIN-301, a soluble recombinant form of the neuregulin-1b1 protein for the treatment of Parkinson's disease and other neurodegenerative disorders. Minerva Neurosciences, Inc. has a license agreement with Mitsubishi Tanabe Pharma Corporation to develop, sell, and import roluperidone globally excluding Asia. The company was formerly known as Cyrenaic Pharmaceuticals, Inc. and changed its name to Minerva Neurosciences, Inc. in 2013. Minerva Neurosciences, Inc. was incorporated in 2007 and is headquartered in Waltham, Massachusetts.
 CEO
 WEBSITEminervaneurosciences.com
 SECTORHealthcare
 INDUSTRYBiotechnology
 EMPLOYEES9

Minerva Neurosciences Inc Frequently Asked Questions

NERV is the stock ticker symbol of Minerva Neurosciences Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Wed Jan 28 2026, market cap of Minerva Neurosciences Inc is 29.16 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check NERV's fair value in chart for subscribers.

The fair value guage provides a quick view whether NERV is over valued or under valued. Whether Minerva Neurosciences Inc is cheap or expensive depends on the assumptions which impact Minerva Neurosciences Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for NERV.

In the past 10 years, Minerva Neurosciences Inc has provided -0.206 (multiply by 100 for percentage) rate of return.